PharVision Advisers’s Amplitude AMPL Stock Holding History

PharVision Advisers’s Portfolio AMPL Stock Details AMPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-16,257	Closed	-$174K	–	686
2025 Q3	$174K	Buy	+16,257	New	+$193K	0.1%	545

Other funds holding AMPL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PharVision Advisers's AMPL Position: Q4 2025 in Review

PharVision Advisers sold out of Amplitude (AMPL) in Q4 2025, closing a stake of 16,257 shares — an estimated $174K sold.

PharVision Advisers first reported a position in AMPL in Q3 2025 and held it in 1 quarter. The position peaked at $174K in Q3 2025. 209 funds tracked by Wall St. Rank hold AMPL as of Q4 2025.

PharVision Advisers reported no remaining Amplitude position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 16,257 Amplitude shares in Q4 2025, an estimated $174K.
PharVision Advisers first reported a position in Amplitude in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Amplitude position peaked at $174K in Q3 2025.
209 funds tracked by Wall St. Rank held Amplitude as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.